Endoscopic Management of Benign Airway Stenosis in Coronavirus Disease 2019 Patients.

This article examines the management of benign airway stenosis in patients with COVID-19. The study compares the results of endoscopic dilation as a treatment for airway stenosis in COVID-19 patients to a control group. The study finds that COVID-19 infection does not negatively impact the success of endoscopic treatment and there is no significant difference in recurrence rates between the COVID-19 group and the control group. The article provides detailed information on the study design, patient data, endoscopic procedures, and statistical analysis. Another study discussed in the article focuses on the management and recurrence of laryngotracheal stenosis (LTS) in COVID-19 patients compared to those without COVID-19. The study finds that COVID-19 patients have a longer intubation time and a lower rate of tracheostomy compared to the control group. The recurrence rate of LTS is similar between the two groups, and COVID-19 infection is not a significant predictive factor for recurrence. Subglottic stenosis and the use of laser are identified as independent prognostic factors for stenosis recurrence. The study concludes that the endoscopic treatment for COVID-19 patients with simple tracheal stenosis should be similar to that for the general population. However, the study acknowledges limitations such as a small sample size and the lack of a standardized treatment protocol. [Extracted from the article]